Market revenue in 2023 | USD 1,411.0 million |
Market revenue in 2030 | USD 2,321.4 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.35% in 2023. Horizon Databook has segmented the U.S. clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing number of clinical trials and rising number of companies offering clinical trial biorepository & archiving solutions are among major factors driving the market growth in the U.S. For instance, according to clinicaltrials.gov., around 362,525 clinical trials were conducted in the U.S., as of 2020.
Major CROs such as Quintiles, Covance, Inc., and PAREXEL International Corporation are situated in this region, which is also a driving factor of clinical trial biorepository & archiving solutions market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account